Vestmark Advisory Solutions’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Vestmark Advisory Solutions's PFE Position: Q1 2026 in Review
Vestmark Advisory Solutions increased its Pfizer (PFE) stake by 667% in Q1 2026, buying an estimated $7.37M and bringing the position to 318,106 shares worth $8.93M. The position accounts for 0.1% of the portfolio, ranked #211.
Vestmark Advisory Solutions first reported a position in PFE in Q1 2019 and has held it in 24 quarters since. The position peaked at $9.58M in Q4 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Vestmark Advisory Solutions held 318,106 shares of Pfizer worth $8.93M as of Q1 2026.
- Vestmark Advisory Solutions bought 276,646 Pfizer shares in Q1 2026, an estimated $7.37M.
- Pfizer made up 0.1% of Vestmark Advisory Solutions's portfolio in Q1 2026, its #211 holding.
- Vestmark Advisory Solutions first reported a position in Pfizer in Q1 2019 and has held it in 24 quarters since.
- Vestmark Advisory Solutions's Pfizer position peaked at $9.58M in Q4 2022.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.